Cargando…
Factors affecting time to brain metastases for stage 2 and 3 breast cancer patients: A large single-institutional analysis with potential screening implications
BACKGROUND: Breast cancer is the second most common cancer associated with brain metastases. The purpose of this study was to identify factors that impact the time to brain metastases in breast cancer patients at a single institution. METHODS: Single institution retrospective study that captured all...
Autores principales: | Cao, Toni Q, Dixit, Karan, Santa-Maria, Cesar, Kumthekar, Priya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954098/ https://www.ncbi.nlm.nih.gov/pubmed/33738445 http://dx.doi.org/10.1093/noajnl/vdab009 |
Ejemplares similares
-
Updates on Molecular Targeted Therapies for Intraparenchymal CNS Metastases
por: Sharma, Akanksha, et al.
Publicado: (2021) -
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma
por: Kumthekar, Priya, et al.
Publicado: (2022) -
State-of-the-art considerations in small cell lung cancer brain metastases
por: Lukas, Rimas V., et al.
Publicado: (2017) -
Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain Metastases
por: Carpenter, David J., et al.
Publicado: (2023) -
Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases
por: Ascha, Mustafa S., et al.
Publicado: (2019)